Litcius/Paper detail

The synthesis and bioactivity of pyrrolo[2,3-d]pyrimidine derivatives as tyrosine kinase inhibitors for NSCLC cells with EGFR mutations

Zhenqiang Xia, Ridong Huang, Xinglong Zhou, Yingying Chai, Hai Chen, Lingling Ma, Quanwei Yu, Ying Li, Weimin Li, Yang He

2021European Journal of Medicinal Chemistry30 citationsDOIOpen Access PDF

Topics & Concepts

PharmacophoreChemistryPyrimidineEGFR inhibitorsTyrosine kinaseIC50KinaseMutantStructure–activity relationshipStereochemistryBiochemistryEpidermal growth factor receptorIn vitroSignal transductionReceptorGeneLung Cancer Treatments and MutationsCancer therapeutics and mechanismsHER2/EGFR in Cancer Research
The synthesis and bioactivity of pyrrolo[2,3-d]pyrimidine derivatives as tyrosine kinase inhibitors for NSCLC cells with EGFR mutations | Litcius